Maternal and Child Health — MCQs

Maternal and Child Health Indian Medical PG Practice Questions and MCQs

Question 271: Child survival index is calculated by?

A. 1000-IMR/10
B. IMR-1000/10
C. 1000-U5MR/10 (Correct Answer)
D. 1.15MR-1000/10

Explanation: ### Explanation **1. Why Option C is Correct:** The **Child Survival Index (CSI)** is a key indicator used in public health to measure the probability of a child surviving until their fifth birthday. It is mathematically derived from the **Under-5 Mortality Rate (U5MR)**. The formula is: **Child Survival Index = (1000 – U5MR) / 10** * **Logic:** The U5MR represents the number of deaths per 1,000 live births before age five. Subtracting this from 1,000 gives the number of survivors per 1,000 births. Dividing by 10 converts this figure into a **percentage (%)**, representing the survival rate. **2. Why Other Options are Incorrect:** * **Option A & B:** These use the **Infant Mortality Rate (IMR)**. While IMR (deaths before age 1) is a sensitive indicator of overall socioeconomic status and healthcare availability, the Child Survival Index specifically focuses on the "Child" period, which conventionally extends to the 5th year of life. * **Option D:** This is a mathematically incorrect distractor with no basis in standard epidemiological formulas. **3. High-Yield Clinical Pearls for NEET-PG:** * **U5MR vs. IMR:** U5MR is considered the best single indicator of social development and well-being, as it reflects nutritional status and the impact of immunization programs more accurately than IMR. * **Child Survival and Safe Motherhood (CSSM) Program:** Launched in India in 1992, it aimed to reduce U5MR and Maternal Mortality. It was later integrated into the RCH program. * **Key Target:** Under the Sustainable Development Goals (SDG 3.2), the target is to reduce U5MR to at least as low as **25 per 1,000 live births** by 2030. * **Calculation Tip:** If a question provides a U5MR of 50, the Child Survival Index would be (1000-50)/10 = 95%.

Question 272: An ASHA worker is typically assigned to serve a population of approximately what size?

A. 3000
B. 1000 (Correct Answer)
C. 5000
D. 400

Explanation: ### Explanation **1. Why Option B is Correct:** The **ASHA (Accredited Social Health Activist)** is a key component of the National Health Mission (NHM). According to the guidelines, there should be one ASHA worker for every **1,000 population** in rural areas. In tribal, hilly, or desert areas with sparse populations, this norm can be relaxed to one ASHA per habitation or per 500-600 population. She acts as a bridge between the community and the public health system, primarily focusing on maternal and child health. **2. Why Other Options are Incorrect:** * **Option A (3000):** This is the population norm for a **Sub-Centre** in hilly, tribal, or difficult areas. In plain areas, a Sub-Centre serves 5,000 people. * **Option C (5000):** This is the population norm for a **Sub-Centre** in plain areas. It is also the population served by one **Multi-Purpose Worker (MPW)** or Health Worker (Male/Female). * **Option D (400):** This is the population norm for an **Anganwadi Worker (AWW)** under the ICDS scheme in rural/urban areas (range: 400–800). **3. High-Yield Clinical Pearls for NEET-PG:** * **Selection:** ASHA must be a woman, resident of the village, married/widowed/divorced, and preferably aged **25–45 years**. * **Education:** She should be literate with formal education up to **Class 10** (relaxed only if no suitable candidate is available). * **Village Health Sanitation and Nutrition Committee (VHSNC):** ASHA acts as the **Member Secretary** of this committee. * **Drug Kit:** She carries a kit containing ORS, Iron Folic Acid (IFA) tablets, chloroquine, disposable delivery kits (DDK), and oral contraceptive pills. * **Remuneration:** She is a volunteer and receives **performance-based incentives** (not a fixed salary).

Question 273: Which of the following is a current indicator of Maternal and Child Health (MCH)?

A. Maternal Mortality Ratio (MMR) of 3-4 per 100,000 live births
B. Infant Mortality Rate (IMR) of 39 per 10,000 live births
C. Delivery by trained personnel of 42% (Correct Answer)
D. All of the above

Explanation: ### Explanation **1. Understanding the Correct Answer (Option C):** Maternal and Child Health (MCH) indicators are used to measure the health status of women and children and the effectiveness of healthcare delivery. **Delivery by trained personnel** is a process indicator that reflects the accessibility and utilization of skilled birth attendance. While the global and national targets aim for much higher coverage (e.g., >90%), the figure of 42% represents a specific historical or regional data point often used in standardized medical examinations to test the recognition of valid MCH metrics. It highlights the gap in professional obstetric care, which is a critical determinant of maternal survival. **2. Why Other Options are Incorrect:** * **Option A (MMR):** The Maternal Mortality Ratio is defined as the number of maternal deaths per **100,000 live births**. However, the value "3-4" is incorrect for India (Current MMR is 97 per lakh live births as per SRS 2018-20). A ratio of 3-4 is only seen in highly developed Scandinavian countries. * **Option B (IMR):** The Infant Mortality Rate is defined as deaths per **1,000 live births**, not 10,000. Using the wrong denominator is a common "trap" in NEET-PG questions. Additionally, India’s current IMR is approximately 28 per 1,000 live births (SRS 2020). **3. High-Yield Clinical Pearls for NEET-PG:** * **MMR Denominator:** Always **100,000 live births** (the only MCH indicator with this denominator). * **IMR Denominator:** Always **1,000 live births**. * **Skill Birth Attendant (SBA):** Includes Doctors, Nurses, and Midwives trained in managing normal deliveries and identifying complications. It does *not* include traditional birth attendants (dais). * **SDG Target 3.1:** Reduce global MMR to less than **70 per 100,000** live births by 2030. * **SDG Target 3.2:** Reduce IMR to at least as low as **25 per 1,000** live births.

Question 274: The maximum number of deaths in children occur in which age group?

A. 2-5 years
B. 1-2 years
C. First 7 days (Correct Answer)
D. 6 months - 12 months

Explanation: **Explanation:** The correct answer is **First 7 days** (Early Neonatal Period). This is a high-yield concept in Community Medicine and Pediatrics, reflecting the extreme vulnerability of the newborn during the transition to extrauterine life. **Why "First 7 days" is correct:** Statistically, the neonatal period (first 28 days) accounts for approximately **45-50% of all under-5 deaths**. Within this period, the risk is highest immediately after birth. About **75% of neonatal deaths occur in the first week of life (early neonatal period)**, and nearly 25-40% occur within the first 24 hours. The primary causes include prematurity/low birth weight, birth asphyxia, and early-onset sepsis. **Why other options are incorrect:** * **Options A & B (1-5 years):** While malnutrition and accidents become more prominent in this age group, the absolute number of deaths is significantly lower than in the neonatal period due to improved immunization and diarrhea management (ORS). * **Option D (6-12 months):** This period carries risks related to weaning and infections (pneumonia, diarrhea), but it does not match the acute physiological fragility seen in the first week of life. **High-Yield NEET-PG Pearls:** * **Early Neonatal Period:** 0-7 days. * **Late Neonatal Period:** 7-28 days. * **Most common cause of Neonatal Mortality in India:** Prematurity/Low Birth Weight. * **Most common cause of Under-5 Mortality in India:** Prematurity (followed by Pneumonia). * **IMR (Infant Mortality Rate):** Defined as deaths per 1,000 live births within the first year. The neonatal component is the largest contributor to IMR.

Question 275: The 'Cafeteria approach' is related to which of the following programs?

A. National Iodine Deficiency Disorder Programme
B. National Anemia Prophylaxis Programme
C. Reproductive and Child Health Programme (Correct Answer)
D. National Vector Borne Disease Control Programme

Explanation: ### Explanation The **'Cafeteria Approach'** is a core philosophy of the **Reproductive and Child Health (RCH) Programme** (and the Family Welfare Programme). It refers to providing a wide range of contraceptive methods to a couple, allowing them to choose the method best suited to their needs, rather than imposing a specific target-based method. #### Why Option C is Correct: * **Concept:** Just as a cafeteria offers various food choices, this approach offers a "menu" of family planning options (e.g., Barrier methods, OCPs, IUDs, Injectables, and Permanent methods). * **Goal:** It emphasizes **informed choice**, individual autonomy, and the shift from a "target-oriented" approach to a "client-centered" approach. This is a fundamental pillar of RCH Phase I (launched in 1997) and Phase II. #### Why Other Options are Incorrect: * **Option A (NIDDCP):** Focuses on the fortification of salt with iodine and monitoring urinary iodine excretion. It is a nutritional supplementation program, not a choice-based service delivery model. * **Option B (Anemia Prophylaxis):** Now part of *Anemia Mukt Bharat*, this program follows a fixed prophylactic and therapeutic regimen (6x6x6 strategy) for Iron and Folic Acid (IFA) supplementation. * **Option D (NVBDCP):** Focuses on vector control (IRS, LLINs) and standardized treatment protocols for diseases like Malaria and Dengue. #### High-Yield Clinical Pearls for NEET-PG: * **Target-Free Approach:** The Cafeteria Approach was strengthened after the 1994 Cairo Conference, leading India to adopt the "Target-Free Approach" (1996), later renamed the **Community Needs Assessment Approach (CNAA)**. * **RCH Phase I:** Launched on **October 15, 1997**. * **Latest Addition:** The newest contraceptive added to the "cafeteria" under the public health system is **Antara** (Injectable MPA) and **Chhaya** (Centchroman). * **Counseling Tool:** The **GATHER** technique (Greet, Ask, Tell, Help, Explain, Return) is used to implement the cafeteria approach effectively.

Question 276: What is the best preventive measure for neural tube defects?

A. Vitamin B12 supplementation to mother
B. Folate supplementation to mother (Correct Answer)
C. BCG vaccination at birth
D. Ultrasound in the 2nd trimester

Explanation: **Explanation:** **1. Why Folate supplementation is correct:** Neural Tube Defects (NTDs), such as anencephaly and spina bifida, occur due to the failure of the neural tube to close between the **21st and 28th day** after conception. Folic acid (Vitamin B9) is a critical co-factor in DNA synthesis and methylation. Adequate periconceptional folate levels significantly reduce the risk of these malformations. Because the neural tube closes before most women realize they are pregnant, supplementation must begin **before conception**. **2. Why other options are incorrect:** * **Vitamin B12:** While B12 deficiency can contribute to NTDs, folic acid is the primary preventive agent proven by large-scale clinical trials. * **BCG vaccination:** This is a live vaccine given at birth to prevent severe forms of tuberculosis (miliary and meningitis); it has no role in embryogenesis. * **Ultrasound in the 2nd trimester:** This is a **diagnostic/screening** tool (Anomaly Scan at 18–20 weeks) to detect existing defects, not a preventive measure. **3. High-Yield Clinical Pearls for NEET-PG:** * **Standard Dose:** 400 mcg (0.4 mg) daily for all women of childbearing age, starting at least 1 month before conception through the 1st trimester. * **High-Risk Dose:** 4 mg (4000 mcg) daily for women with a previous history of a child with NTD or those on anti-epileptic drugs (e.g., Valproate). * **Public Health Strategy:** Under the *Anemia Mukt Bharat* guidelines, WIFS (Weekly Iron and Folic Acid Supplementation) provides 500 mcg of Folic Acid to adolescent girls to ensure baseline levels are maintained.

Question 277: Which of the following states is part of the Empowered Action Group?

A. Maharashtra
B. Karnataka
C. Kerala
D. Orissa (Correct Answer)

Explanation: **Explanation:** The **Empowered Action Group (EAG)** states are a group of eight socio-demographically backward states in India that receive special focus under the National Health Mission (NHM) due to their high infant mortality rates (IMR), maternal mortality ratios (MMR), and total fertility rates (TFR). 1. **Why Orissa is Correct:** Orissa (Odisha) is one of the original eight EAG states. These states were identified to facilitate targeted interventions for stabilizing population growth and improving maternal and child health outcomes. The eight EAG states are: **Bihar, Jharkhand, Madhya Pradesh, Chhattisgarh, Orissa, Rajasthan, Uttar Pradesh, and Uttarakhand.** (Note: These are often referred to as the "BIMARU" states plus their bifurcated counterparts). 2. **Why the others are Incorrect:** * **Maharashtra, Karnataka, and Kerala** are categorized as **Non-EAG states**. These states have historically better health infrastructure and have already achieved or are close to achieving replacement-level fertility and lower mortality indices compared to the national average. Kerala, in particular, is often the benchmark for the best health indicators in India. **High-Yield Clinical Pearls for NEET-PG:** * **EAG + 3:** In many NHM schemes, the focus is on "EAG states, North-Eastern states, Jammu & Kashmir, and Himachal Pradesh." * **Asha Workers:** The ASHA (Accredited Social Health Activist) program was initially launched primarily for these EAG states before being scaled nationwide. * **Demographic Transition:** EAG states are currently in the late second or early third stage of demographic transition, whereas states like Kerala have reached the fourth stage. * **Mnemonic:** Remember **"BIG M-O-U-R-N"** (Bihar, Jharkhand, MP, Chhattisgarh, Orissa, UP, Rajasthan, North/Uttarakhand) to recall the EAG states.

Question 278: Reproductive and Child Health (RCH) Phase I does not include which of the following components?

A. Family planning
B. Immunization
C. Child Survival and Safe Motherhood (CSSM)
D. Emergency obstetric care (Correct Answer)

Explanation: **Explanation:** The **Reproductive and Child Health (RCH) Phase I**, launched in **1997**, was designed to provide an integrated approach to maternal and child health. It aimed to consolidate several pre-existing programs into a single package. **Why Emergency Obstetric Care (EmOC) is the correct answer:** While RCH Phase I focused on "Safe Motherhood," it primarily emphasized essential obstetric care and the prevention of complications. **Emergency Obstetric Care (EmOC)**, specifically the establishment of First Referral Units (FRUs) and 24-hour emergency services, became a core, structured focus during **RCH Phase II (launched in 2005)**. In Phase I, the infrastructure for handling obstetric emergencies was still in its nascent stages and was not a standalone primary component compared to the basic services. **Analysis of Incorrect Options:** * **Family Planning:** This was a foundational pillar of RCH Phase I, shifting the focus from "targets" to a "target-free," client-centered approach. * **Immunization:** The Universal Immunization Programme (UIP) was fully integrated into RCH Phase I to reduce infant and child mortality. * **Child Survival and Safe Motherhood (CSSM):** The CSSM program (launched in 1992) was the immediate precursor to RCH. All its components (ORT, Vitamin A prophylaxis, etc.) were absorbed into RCH Phase I. **High-Yield Clinical Pearls for NEET-PG:** * **RCH Phase I (1997):** Focused on integration and the "Target Free Approach." * **RCH Phase II (2005):** Introduced the **NRHM** alignment, focusing on **EmOC**, Newborn Care, and the **Janani Suraksha Yojana (JSY)**. * **RMNCH+A (2013):** Added the "Adolescent" health component and emphasized the "Continuum of Care" across the life cycle.

Question 279: What is the recommended total number of iron and folic acid tablets to be given to a pregnant woman?

A. 70
B. 90
C. 100 (Correct Answer)
D. 150

Explanation: **Explanation** The correct answer is **100** (Option C). This recommendation is based on the guidelines provided by the **Anemia Mukt Bharat (AMB)** strategy and the **Reproductive, Maternal, Newborn, Child and Adolescent Health (RMNCH+A)** program in India. **1. Why 100 is correct:** For the prevention of iron deficiency anemia during pregnancy, every pregnant woman is recommended to consume **one tablet of Iron and Folic Acid (IFA) daily for at least 100 days**, starting from the second trimester (after the first 12-13 weeks of pregnancy). * **Composition:** Each tablet contains **60 mg of elemental iron** and **500 mcg (0.5 mg) of folic acid**. * **Note:** If a woman is diagnosed with clinical anemia (Hb < 11 g/dL), the dose is doubled to two tablets daily for 180 days. **2. Why other options are incorrect:** * **A (70) & B (90):** These numbers do not align with any national health program guidelines for maternal supplementation. * **D (150):** While some older guidelines or specific regional protocols suggested longer durations, the standard benchmark for "minimum adequate supplementation" in national surveys (like NFHS) and public health exams remains 100 tablets. **High-Yield Clinical Pearls for NEET-PG:** * **Postpartum Care:** The same regimen (100 tablets) is also recommended for **lactating mothers** for the first six months postpartum. * **Adolescents (WIFS):** Weekly Iron and Folic Acid Supplementation (WIFS) involves one tablet per week (60mg Iron + 500mcg Folic Acid) for 52 weeks a year. * **Prophylaxis vs. Treatment:** Always distinguish between prophylaxis (100 days) and treatment of anemia (180 days/6 months). * **Deworming:** Pregnant women should also receive a single dose of **Albendazole (400 mg)** after the first trimester to manage helminthic infections contributing to anemia.

Question 280: What is the recommended regimen to prevent vertical transmission of HIV in a child born to a mother with HIV?

A. Zidovudine for the mother starting at 36 weeks of gestation and for the child for 6 weeks postpartum. (Correct Answer)
B. Zidovudine for 6 months to the mother and 6 weeks to the child.
C. Zidovudine for 6 weeks to the child only.
D. Avoidance of zidovudine during pregnancy and postpartum.

Explanation: The prevention of Parent-to-Child Transmission (PPTCT) of HIV is a high-yield topic for NEET-PG. The goal is to reduce the viral load in the mother and provide pre-exposure prophylaxis to the infant. **Explanation of the Correct Answer (A):** The standard protocol (based on WHO and NACO guidelines for specific scenarios) aims to cover the period of highest transmission risk: late pregnancy, labor, and the early neonatal period. Administering **Zidovudine (AZT)** to the mother starting at **36 weeks** reduces the maternal viral load before delivery. Continuing AZT for the infant for **6 weeks** postpartum provides post-exposure prophylaxis against virus encountered during birth or through early breastfeeding. **Analysis of Incorrect Options:** * **Option B:** Giving AZT for 6 months to the mother is not the standard prophylaxis regimen; modern PPTCT focuses on lifelong ART (Option B is an arbitrary timeframe). * **Option C:** Treating the child only is insufficient. Since the highest risk of transmission occurs during the third trimester and delivery, maternal intervention is crucial to lower the viral "inoculum." * **Option D:** Zidovudine is a cornerstone of PPTCT and is not contraindicated; avoiding it would significantly increase the risk of vertical transmission. **High-Yield Clinical Pearls for NEET-PG:** * **Current NACO Policy:** In India, the current "Option B+" strategy mandates that **all** pregnant women living with HIV should be started on lifelong **ART (TDF + 3TC + EFV/DTG)** regardless of CD4 count. * **Infant Prophylaxis:** If the mother is on stable ART, the infant typically receives **Nevirapine (NVP)** syrup for 6 weeks. If the mother is not stable or diagnosed late, dual prophylaxis (NVP + AZT) may be used. * **Breastfeeding:** Exclusive breastfeeding is recommended for the first 6 months, provided the mother is adherent to ART. * **Diagnosis in Infants:** HIV in infants <18 months is diagnosed via **DNA-PCR** (not ELISA, due to maternal antibodies).

Practice by Chapter

Maternal Mortality: Causes and Prevention

Practice Questions

Antenatal Care

Practice Questions

Intranatal Care

Practice Questions

Postnatal Care

Practice Questions

High-Risk Pregnancy Management

Practice Questions

Infant Mortality: Causes and Prevention

Practice Questions

Under-Five Mortality

Practice Questions

Integrated Management of Neonatal and Childhood Illness

Practice Questions

School Health Services

Practice Questions

Adolescent Health

Practice Questions

Reproductive and Child Health Programs

Practice Questions

International Maternal and Child Health Initiatives

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free